GlobeNewswire
16422 POSTS
0 COMMENTS
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Beef. It’s What’s For Dinner. Wraps Up 2019 by Reaching Consumers more than 1 Billion times with Content Showcasing Real Beef and Real Farmers and Ranchers
GlobeNewswire - 0
DENVER, Dec. 23, 2019 (GLOBE NEWSWIRE) -- Two years after it was relaunched, the Beef. It’s What’s For Dinner. brand has had a reach of more than 1 billion consumers with drool worthy and informative digital marketing and social media content. Funded by the Beef Checkoff and developed by...
Global Small Satellite Market to 2024: Growing Demand for Low-cost Miniaturized Satellites, and Increasing Demand for Earth Observation Applications
GlobeNewswire - 0
Dublin, Dec. 23, 2019 (GLOBE NEWSWIRE) -- The "Small Satellite Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. The small satellite market is estimated to register a CAGR of more than 17% during the forecast periodHuge investments by the venture companies,...
GBT BitSpeed Corp., a Joint Venture between GBT and BitSpeed, announces that BitSpeed has been Recertified as a Cloud Platform Technology Partner
GlobeNewswire - 0
SANTA MONICA, Calif., Dec. 23, 2019 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or “the Company”), a company specializing in the development of Internet of Things (IoT) and Artificial Intelligence (AI) enabled networking and tracking technologies, including its GopherInsight™ wireless mesh network technology platform for both...
Progenics Pharmaceuticals Announces Phase 3 CONDOR Trial of PyL™ in Prostate Cancer Achieved Primary Endpoint
GlobeNewswire - 0
- Met Primary Endpoint With a Correct Localization Rate of 84.8–87.0%, Highlighting Strong Diagnostic Performance- Company Expects to Submit an NDA to the FDA in the Second Half of 2020- Conference Call at 8:00 AM Eastern TimeNEW YORK, Dec. 23, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an...
Dublin, Dec. 23, 2019 (GLOBE NEWSWIRE) -- The "Digital Technologies: New Strategies for Customer Engagement" report has been added to ResearchAndMarkets.com's offering. New Strategies for Customer Engagement enables you to take stock of your current position and progress before setting out your strategy for further digital transformation over the...
United States Autonomous Car Market to 2024: Market is Expected to Register a CAGR of 46.39%
GlobeNewswire - 0
Dublin, Dec. 23, 2019 (GLOBE NEWSWIRE) -- The "United States Autonomous Car Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. The US autonomous car market is anticipated to register a CAGR of about 46.39% during the forecast period, 2019-2024Autonomous cars use...
NIO Inc. to Report Third Quarter 2019 Financial Results on Monday, December 30, 2019
GlobeNewswire - 0
SHANGHAI, China, Dec. 23, 2019 (GLOBE NEWSWIRE) -- NIO Inc. (“NIO” or the “Company”) (NYSE: NIO), a pioneer in China’s premium electric vehicle market, today announced that it will report its third quarter 2019 unaudited financial results on Monday, December 30, 2019, before the open of the U.S. markets.The...
WISeKey to Hold its 13th Annual Cybersecurity IoT Blockchain Roundtable in Davos on January 22, 2020
GlobeNewswire - 0
WISeKey to Hold its 13th Annual Cybersecurity IoT Bloackchain Roundtable in Davos on January 22, 2020Geneva – December 23, 2019 - WISeKey International Holding Ltd ("WISeKey", SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity and IoT company, today announces that it will hold its 13th Annual Cybersecurity Roundtable in Davos...
Progenics Pharmaceuticals to Announce and Host a Conference Call to Discuss Top Line Results from Phase 3 CONDOR Trial of PyL™ in Prostate Cancer on Monday, December 23rd
GlobeNewswire - 0
NEW YORK, Dec. 22, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative targeted medicines and artificial intelligence to find, fight and follow cancer, today announced that it will host a conference call to review the top line results from the Phase 3 CONDOR trial...